% | $
Quotes you view appear here for quick access.

Amarantus Bioscience Holdings, Inc Message Board

  • solantey Feb 14, 2013 8:52 AM Flag

    My View on AMBS

    There's an old adage in the restaurant business that says "sell the sizzle and not the steak".

    In the last two months the company has been putting on a strong p.r. campaign to "sell the sizzle" related to the "potential" that the MANF technology may offer long term.

    Yesterday's SeekingAlpha article addressed the "sizzle". Supposebly the next article will address the "steak" or financial situation that exists.

    Let's consider the facts related to the company. The last filing showed that the company had less than $600 in cash on hand. Last week the company announced additional loans from Dominion Capital a portion of which allowed for immediate conversion into 25,000,000 shares of common stock at a conversion price of .015/share. It's anticipated that the company will announce a loss in excess of $4,000,000 for 2012 with only three employees.

    In November the company increased the number of authorized shares to 1,000,000,000. It's doubtful that the company can continue to operate on the basis of continuing to issue convertible notes with terms similar to the one I referenced. The next logical step is a secondary offering of 100,000,000 shares at .06/share with attached warrants convertible at .10 with a one year expiration date. This would allow the company to raise $16,000,000 with 200,000,000 shares being sold.

    Note to Gerald: I think this is the best type of deal available to the company.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
0.0340.000(0.00%)Oct 24 3:59 PMEDT